Elsevier

Toxicology

Volume 126, Issue 3, 3 April 1998, Pages 155-162
Toxicology

Glutathione S-transferase Mu (GST Mu) deficiency and DNA adducts in lymphocytes of smokers

https://doi.org/10.1016/S0300-483X(98)00010-9Get rights and content

Abstract

The effect of smoking on DNA adduct formation in lymphocytes was analysed in individuals with low (deficient) and high (non-deficient) glutathione S-transferase (class Mu) activity. DNA adduct levels in lymphocytes were determined by the highly sensitive nuclease P1-enhanced 32P-postlabeling assay. The lymphocyte DNA adducts/108 nucleotides of smokers deficient in glutathione S-transferase Mu activity (n=12) were significantly higher than those of smokers non-deficient (n=9) in glutathione S-transferase Mu activity. The DNA adduct levels of the lymphocytes inversely correlated with glutathione S-transferase Mu activity. A correlation was found between DNA adduct levels and daily cigarette consumption. Results of the present study suggest that individuals deficient in glutathione S-transferase Mu activity may be at greater risk of DNA damage.

Introduction

In humans there are three distinct classes of GST isozymes based on isoelectric point: the acidic or Pi form (Guthenberg et al., 1979), the near neutral or Mu form (Warholm et al., 1980), and the basic or alpha form (Kamisaka et al., 1975). These isozymes have different and overlapping substrate specificities and are variably expressed in different tissues. For example, the alpha form is found in adult livers of all individuals but the GST Mu isozyme also referred to as GSTM1 is detected in about half of the Caucasian population (Hussey et al., 1987). A large concentration of the Mu form is found in the liver, adrenal gland and leukocytes, and is highly active towards benzo(a)pyrene-4,5-oxide and styrene-7,8-oxide (Warholm et al., 1981, Warholm et al., 1983). In humans, the GST activity towards trans-stilbene oxide, is identical with the hepatic Mu form (Seidegard et al., 1987). There is a hereditary polymorphism of this isozyme in the Caucasian population (Seidegard and Pero, 1985) and the gene expression of Mu has been proposed to be a host determinant of susceptibility to smoking-related cancer (Seidegard et al., 1990, Lafuente et al., 1993, Nakajima et al., 1995).

Recently, 32P-postlabeling studies demonstrated the presence of smoking-associated aromatic DNA adducts in tissues that are targets for tobacco smoke-related carcinogenesis (Reddy and Randerath, 1986Phillips et al., 1988Savela et al., 1989Phillips et al., 1990). Lung and/or bronchial tissues were used in order to evaluate adduct concentration in smokers and non-smokers and interesting results were reported. Gallagher et al. (1993)succeeded in showing a specific smokers-associated DNA, not co-migrating with the major benzo(a)pyrene adduct in lymphocytes and concluded that smoking-related DNA adduct levels are elevated, when compared to non-smokers.

The present studies were designed to determine whether the human GST Mu polymorphism influences in vivo DNA adduct formation in smokers. In the present study lymphocytes of smokers with low or high GST Mu activity towards trans-stilbene oxide were compared for the presence of DNA adducts.

Section snippets

Materials

Materials required for the 32P-postlabelling adduct assay were those described by Gupta (1985). The fine chemicals including Ficoll-Paque and nuclease P1 were obtained from Sigma (St. Louis, MO). All other chemicals used were of highest purity available. Carrier-free [32P]orthophosphate (100–150 mCi/ml) used for the synthesis of ATP was obtained from the Bhabha Atomic Research Centre, Mumbai, India. Tritiated trans-stilbene oxide 15 Ci/mmol was obtained from American Radiolabelled Chemicals

GST Mu activity in human lymphocytes

GST Mu activity was measured in each individual. As shown in Fig. 1, analysis of GST Mu towards trans-stilbene oxide in human lymphocytes revealed definitive interindividual variation of GST Mu activity, which allows precise categorization of an individual as a high or low conjugator. Of the 21 subjects studied, nine had measurable or high (greater than 50 pmol conjugate formed/min per mg protein) levels of the enzyme activity, whereas 11 had negligible levels (less than 11 pmol conjugate

Discussion

Lymphocytes have been used for investigating genotoxicity of foreign chemicals by measuring end points such as chromosomal changes, DNA adducts and gene mutation (Lucier and Thompson, 1987). Several occupational studies have reported elevated levels of polycyclic aromatic hydrocarbons (PAH-type) DNA adducts present in peripheral white blood cells of exposed workers (Phillips et al., 1988, Savela et al., 1989, Schoket, 1993), but no significant effects of smoking have been reported. The

Acknowledgements

We are grateful to Dr Vinodini Reddy, Former Director, National Institute of Nutrition, for her encouragement and interest in this study. We thank Mr D. Seshadri for his excellent technical assistance, and Mr Vidya Sagar and Mr V.V. Rao for their help in the statistical analysis of the data. This work was supported by Council of Scientific and Industrial Research, India (13(6418-A)/91-pool).

References (32)

  • R.C. Gupta

    Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen-DNA adducts

    Cancer Res.

    (1985)
  • R.C. Gupta et al.

    32P-postlabeling analysis of non-radioactive aromatic carcinogen DNA adducts

    Carcinogenesis

    (1982)
  • R.C. Gupta et al.

    Formation of cigarette smoke induced DNA adducts in rat lung and nasal mucosa

    Cancer Res.

    (1989)
  • C. Guthenberg et al.

    Purification of glutathione S-transferase from human placentas

    Acta Chim. Scand.

    (1979)
  • C.C. Harris

    Interindividual variations among humans in carcinogen metabolism. DNA adduct formation and DNA repair

    Carcinogenesis

    (1989)
  • S.S. Hecht et al.

    Tobacco specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke

    Carcinogenesis

    (1988)
  • Cited by (0)

    View full text